THE USE OF NUCLEAR-MAGNETIC-RESONANCE IMAGING IN MONITORING TOTAL-BODY IRON IN HEMODIALYSIS-PATIENTS WITH HEMOSIDEROSIS TREATED WITH ERYTHROPOIETIN AND PHLEBOTOMY

被引：12

作者：

CHAN, PCK

LIU, P

CRONIN, C

HEATHCOTE, J

ULDALL, R

机构：

[1] UNIV TORONTO, TORONTO GEN HOSP, DIV NEPHROL, TORONTO M5G 1L7, ONTARIO, CANADA

[2] UNIV TORONTO, TORONTO GEN HOSP, DIV RADIOL, TORONTO M5G 1L7, ONTARIO, CANADA

[3] UNIV TORONTO, TORONTO GEN HOSP, DIV GASTROENTEROL & HEPATOL, TORONTO M5G 1L7, ONTARIO, CANADA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 1992年 / 19卷 / 05期

关键词：

HEMOSIDEROSIS; HEMODIALYSIS; ERYTHROPOIETIN; PHLEBOTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING;

D O I：

10.1016/S0272-6386(12)80959-0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Two hemodialysis patients with hemosiderosis were treated with combined erythropoietin and repeated phlebotomy. Serial nuclear magnetic resonance (NMR) imaging and serum ferritin levels were used to monitor the efficacy of treatment. This treatment modality has definite advantages over chronic deferoxamine therapy. NMR image-derived parameters offer an objective, accurate, and noninvasive indication of tissue iron stores. © 1992, National Kidney Foundation. All rights reserved. All rights reserved.

引用

页码：484 / 489

页数：6

共 29 条

[1]

ALI M, 1980, JAMA-J AM MED ASSOC, V244, P343

[2]

Baker L R, 1976, Clin Nephrol, V6, P326

[3]

BOELAERT JR, 1988, CLIN NEPHROL, V29, P261

[4] USEFULNESS AND LIMITATIONS OF LABORATORY AND HEPATIC IMAGING STUDIES IN IRON-STORAGE DISEASE [J].